Clinical Trials

You are here >>:Home/News/Research & Studies/Clinical Trials

Tcelna Heads to Phase IIb

2017-01-04T11:48:58+00:00 Clinical Trials, MS|

Tcelna, a potential T-cell therapy for secondary-progressive MS as well as relapsing-remitting MS, is gearing up for its Phase IIb clinical trials. According to Opexa Therapeutics, Tcelna is the first-ever personalized T-cell therapy for MS, [...]